The Glasgow Prognostic Score Predicts Outcomes of Pembrolizumab or Atezolizumab Monotherapy in Patients with Pretreated Non-Small Cell Lung Cancer

INTRODUCTION: Predictors of the effectiveness of immune checkpoint inhibitor (ICI) monotherapy in previously treated patients with non-small cell lung cancer (NSCLC) remain ill-defined. We investigated whether the Glasgow prognostic score (GPS) could serve as such predictors. METHODS: Eighty patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Kasajima, Masashi, Igawa, Satoshi, Manaka, Hiroya, Yamada, Kaori, Akazawa, Yuki, Manabe, Hideaki, Yagami, Yuri, Yamamoto, Hiroki, Ito, Hiroki, Kaizuka, Nobuki, Nakahara, Yoshiro, Sato, Takashi, Mitshufuji, Hisashi, Yokoba, Masanori, Kubota, Masaru, Sasaki, Jiichiro, Naoki, Katsuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9872847/
https://www.ncbi.nlm.nih.gov/pubmed/36103811
http://dx.doi.org/10.1159/000526964

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9872847/
https://www.ncbi.nlm.nih.gov/pubmed/36103811
http://dx.doi.org/10.1159/000526964

Ejemplares similares